MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2

Biology Open

Volumn 5, Issue 5, 2016, Pages 563-570

  Wu, Haijun ^a   Liang, Yu ^a   Shen, Lin ^a   Shen, Liangfang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 Fu; Colorectal cancer; HMGA2; miR 204

Indexed keywords

FLUOROURACIL; HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA 204; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84978710325     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.015008     Document Type: Article

References (39)

1. Allen, J. E., Gallant, J.-N., Dicker, D. T., Amin, S., Irby, R. B., Sharma, A. K. and El-Deiry, W. S. (2013). The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer. PLoS ONE 8, e59380.
2. Bao, W., Wang, H.-H., Tian, F.-J., He, X.-Y., Qiu, M.-T., Wang, J.-Y., Zhang, H.-J., Wang, L.-H. and Wan, X.-P. (2013). A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol. Cancer 12, 155.
3. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Chen, Z., Sangwan, V., Banerjee, S., Mackenzie, T., Dudeja, V., Li, X., Wang, H., Vickers, S. M. and Saluja, A. K. (2013). miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death. Mol. Cancer 12, 105.
5. Chen, F., Zhuang, M., Zhong, C., Peng, J., Wang, X., Li, J., Chen, Z. and Huang, Y. (2015). Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1alpha signaling pathway. Oncol. Rep. 33, 457-463.
6. Chung, T. K. H., Lau, T. S., Cheung, T. H., Yim, S. F., Lo, K. W. K., Siu, N. S. S., Chan, L. K. Y., Yu, M. Y., Kwong, J., Doran, G. et al. (2012). Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int. J. Cancer 130, 1036-1045.
7. Cleynen, I. and Van de Ven, W. J. M. (2008). The HMGA proteins: a myriad of functions (Review). Int. J. Oncol. 32, 289-305.
8. Dalianis, T. (2014). Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review). Int. J. Oncol. 44, 1799-1805.
9. Das, D., Satapathy, S. R., Siddharth, S., Nayak, A. and Kundu, C. N. (2015). NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade. Cancer Chemother. Pharmacol. 76, 471-479.
10. Di Leva, G., Garofalo, M. and Croce, C. M. (2014). MicroRNAs in cancer. Annu. Rev. Pathol. 9, 287-314.
11. Esquela-Kerscher, A. and Slack, F. J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
12. Friedman, R. C., Farh, K. K.-H., Burge, C. B. and Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105.
13. Fusco, A. and Fedele, M. (2007). Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899-910.
14. Gong, M., Ma, J., Li, M., Zhou, M., Hock, J. M. and Yu, X. (2012). MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro Oncol. 14, 1007-1017.
15. He, L. and Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
16. Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W. and Du, X. (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118-126.
17. Huang, Z., Huang, S., Wang, Q., Liang, L., Ni, S., Wang, L., Sheng, W., He, X. and Du, X. (2011). MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res. 71, 2582-2589.
18. Hwang, H. W. and Mendell, J. T. (2007). MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 96 Suppl., R40-R44.
19. Kerr, J. F. R., Winterford, C. M. and Harmon, B. V. (1994). Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026.
20. Kim, T. H., Song, J.-Y., Park, H., Jeong, J.-Y., Kwon, A.-Y., Heo, J. H., Kang, H., Kim, G. and An, H. J. (2015). miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett. 356, 937-945.
21. Lee, Y., Yang, X., Huang, Y., Fan, H., Zhang, Q., Wu, Y., Li, J., Hasina, R., Cheng, C., Lingen, M. W. et al. (2010). Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput. Biol. 6, e1000730.
22. Li, Y., He, J., Zhong, D., Li, J. and Liang, H. (2015). High-mobility group box 1 protein activating nuclear factor-kappaB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer. J. Int. Med. Res. 43, 494-505.
23. Liu, J., Ma, L., Wang, Z., Wang, L., Liu, C., Chen, R. and Zhang, J. (2014). MicroRNA expression profile of gastric cancer stem cells in the MKN-45 cancer cell line. Acta. Biochim. Biophys. Sin. 46, 92-99.
24. Manikandan, J., Aarthi, J. J., Kumar, S. D. and Pushparaj, P. N. (2008). Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2, 330-334.
25. Mikhaylova, O., Stratton, Y., Hall, D., Kellner, E., Ehmer, B., Drew, A. F., Gallo, C. A., Plas, D. R., Biesiada, J., Meller, J. et al. (2012). VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 21, 532-546.
26. Miyazawa, J., Mitoro, A., Kawashiri, S., Chada, K. K. and Imai, K. (2004). Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res. 64, 2024-2029.
27. Monzen, K., Ito, Y., Naito, A. T., Kasai, H., Hiroi, Y., Hayashi, D., Shiojima, I., Yamazaki, T., Miyazono, K., Asashima, M. et al. (2008). A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat. Cell Biol. 10, 567-574.
28. Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M. and Sung, J. J. Y. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375-1381.
29. Nishino, J., Kim, I., Chada, K. and Morrison, S. J. (2008). Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135, 227-239.
30. Qiu, Y.-H., Wei, Y.-P., Shen, N.-J., Wang, Z.-C., Kan, T., Yu, W.-L., Yi, B. and Zhang, Y.-J. (2013). miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells. Cell. Physiol. Biochem. 32, 1331-1341.
31. Sacconi, A., Biagioni, F., Canu, V., Mori, F., Di Benedetto, A., Lorenzon, L., Ercolani, C., Di Agostino, S., Cambria, A. M., Germoni, S. et al. (2012). miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis. 3, e423.
32. Sarhadi, V. K., Wikman, H., Salmenkivi, K., Kuosma, E., Sioris, T., Salo, J., Karjalainen, A., Knuutila, S. and Anttila, S. (2006). Increased expression of high mobility group A proteins in lung cancer. J. Pathol. 209, 206-212.
33. Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H. et al. (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425-436.
34. Shin, J.-Y., Kim, J.-O., Lee, S. K., Chae, H.-S. and Kang, J.-H. (2010). LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer 10, 425.
35. Siegel, R. L., Miller, K. D. and Jemal, A. (2015). Cancer statistics, 2015. CA Cancer J. Clin. 65, 5-29.
36. Sun, S., Zhang, W., Cui, Z., Chen, Q., Xie, P., Zhou, C., Liu, B., Peng, X. and Zhang, Y. (2015). High mobility group box-1 and its clinical value in breast cancer. Onco. Targets Ther. 8, 413-419.
37. Wang, Q., Huang, Z., Guo, W., Ni, S., Xiao, X., Wang, L., Huang, D., Tan, C., Xu, Q., Zha, R. et al. (2014). microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma. Clin. Cancer Res. 20, 1146-1157.
38. Yin, Y., Zhang, B., Wang, W., Fei, B., Quan, C., Zhang, J., Song, M., Bian, Z., Wang, Q., Ni, S. et al. (2014). miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin. Cancer Res. 20, 6187-6199.
39. Ying, Z., Li, Y., Wu, J., Zhu, X., Yang, Y., Tian, H., Li, W., Hu, B., Cheng, S.-Y. and Li, M. (2013). Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 73, 990-999.